Want to join the conversation?
$THC 2Q15 Call: Inpatient volumes were relatively strong on a historical basis with growth of 1.7% over 2Q14 making it one of the top 10 volume quarters over the past decade. With USPI and Aspen now part of THC operations, added new Ambulatory Care segment. Taking steps to improve Acute Care portfolio.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?